TrialHeadache2021

Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double-blind, placebo-controlled study.

Takao Takeshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.